A label-free impedance biosensing assay based on CRISPR/Cas12a collateral activity for bacterial DNA detection
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 204, 114268
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas SystemCell, 2015
- Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from bloodClinical Microbiology and Infection, 2015
- Developments for improved diagnosis of bacterial bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Electrochemical impedance spectroscopy: an overview of bioanalytical applicationsAnalytical Methods, 2013
- Probe accessibility effects on the performance of electrochemical biosensors employing DNA monolayersAnalytical and Bioanalytical Chemistry, 2011
- Label-free monitoring of site-specific DNA cleavage by EcoRI endonuclease using cyclic voltammetry and electrochemical impedanceAnalytica Chimica Acta, 2009
- A label-free DNA sensor based on impedance spectroscopyElectrochimica Acta, 2008
- Preparation of electrode-immobilized, redox-modified oligonucleotides for electrochemical DNA and aptamer-based sensingNature Protocols, 2007
- PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settingsThe Lancet Infectious Diseases, 2004
- Immobilization of Nucleic Acids at Solid Surfaces: Effect of Oligonucleotide Length on Layer AssemblyBiophysical Journal, 2000